Cargando…

Zastosowanie Wemurafenibu w Opornej Na Leczenie Histiocytozie z Komórek Langerhansa

Langerhans Cell Histiocytosis (LCH) is a rare disease involving the occurrence of disturbances in the mitogene-activated kinases pathway (MAPK). At present, it is known that the appearance of such disorders is usually connected with a more aggressive form of the disease, more frequently resistant to...

Descripción completa

Detalles Bibliográficos
Autores principales: Raciborska, Anna, Małas, Zofia, Tysarowski, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522826/
https://www.ncbi.nlm.nih.gov/pubmed/30636236
http://dx.doi.org/10.34763/devperiodmed.20182204.376378